Date:23/12/2008 URL: http://www.thehindu.com/2008/12/23/stories/2008122356911600.htm
Back



Business - Briefly

Aurobindo Pharma gets USFDA nod

HYDERABAD: Aurobindo Pharma has received tentative approval to manufacture and market fixed dosed combination, Abacavir Sulfate / Lamivudine tablets 60/30 mg from the U.S. Food and Drug Administration (USFDA). The drug was meant for treatment of HIV infections. — Special Correspondent

© Copyright 2000 - 2009 The Hindu